261 related articles for article (PubMed ID: 31058850)
1. Homeobox Genes and Hepatocellular Carcinoma.
Liu KY; Wang LT; Hsu SH; Wang SN
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31058850
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
3. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
Yang Q; Zhang Q; Zhang X; You L; Wang W; Liu W; Han Y; Ma C; Xu W; Chen J; Yang H; Wan P; Zhou Y; Liu Y; Wu K; Yang Z; Wu J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674631
[TBL] [Abstract][Full Text] [Related]
4. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
[TBL] [Abstract][Full Text] [Related]
5. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analysis and prediction of the function and regulatory network of long non-coding RNAs in hepatocellular carcinoma.
Cao MR; Han ZP; Liu JM; Li YG; Lv YB; Zhou JB; He JH
Oncol Lett; 2018 May; 15(5):7783-7793. PubMed ID: 29740493
[TBL] [Abstract][Full Text] [Related]
7. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
[TBL] [Abstract][Full Text] [Related]
8. Links between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular Carcinoma.
Honda T
Front Chem; 2016; 4():21. PubMed ID: 27242996
[TBL] [Abstract][Full Text] [Related]
9. miRNA in hepatocellular carcinoma.
Morishita A; Masaki T
Hepatol Res; 2015 Jan; 45(2):128-41. PubMed ID: 25040738
[TBL] [Abstract][Full Text] [Related]
10. The role of homeobox genes in hematopoiesis.
Magli MC
Biotherapy; 1998; 10(4):279-94. PubMed ID: 9592016
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.
Lee WY; Bachtiar M; Choo CCS; Lee CG
Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774
[TBL] [Abstract][Full Text] [Related]
12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.
Selitsky SR; Dinh TA; Toth CL; Kurtz CL; Honda M; Struck BR; Kaneko S; Vickers KC; Lemon SM; Sethupathy P
mBio; 2015 Dec; 6(6):e01500-15. PubMed ID: 26646011
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma: Etiology and Current and Future Drugs.
Jindal A; Thadi A; Shailubhai K
J Clin Exp Hepatol; 2019; 9(2):221-232. PubMed ID: 31024205
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
Herceg Z; Paliwal A
Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
[TBL] [Abstract][Full Text] [Related]
16. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
[TBL] [Abstract][Full Text] [Related]
17. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance.
Karin M
Precis Clin Med; 2018 Jun; 1(1):21-28. PubMed ID: 30687560
[TBL] [Abstract][Full Text] [Related]
18. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
19. The aberrant expressions of MACC1, ZEB1, and KLF4 in hepatocellular carcinoma and their clinical significance.
Chen J; Zhang L; Ma S; Lu G; Wang D
Int J Clin Exp Pathol; 2019; 12(9):3653-3661. PubMed ID: 31934216
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma.
Ji X; Zhang Q; Du Y; Liu W; Li Z; Hou X; Cao G
Curr Genomics; 2014 Dec; 15(6):469-80. PubMed ID: 25646075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
